Literature DB >> 21399646

Alum interaction with dendritic cell membrane lipids is essential for its adjuvanticity.

Tracy L Flach1, Gilbert Ng, Aswin Hari, Melanie D Desrosiers, Ping Zhang, Sandra M Ward, Mark E Seamone, Akosua Vilaysane, Ashley D Mucsi, Yin Fong, Elmar Prenner, Chang Chun Ling, Jurg Tschopp, Daniel A Muruve, Matthias W Amrein, Yan Shi.   

Abstract

As an approved vaccine adjuvant for use in humans, alum has vast health implications, but, as it is a crystal, questions remain regarding its mechanism. Furthermore, little is known about the target cells, receptors, and signaling pathways engaged by alum. Here we report that, independent of inflammasome and membrane proteins, alum binds dendritic cell (DC) plasma membrane lipids with substantial force. Subsequent lipid sorting activates an abortive phagocytic response that leads to antigen uptake. Such activated DCs, without further association with alum, show high affinity and stable binding with CD4(+) T cells via the adhesion molecules intercellular adhesion molecule-1 (ICAM-1) and lymphocyte function-associated antigen-1 (LFA-1). We propose that alum triggers DC responses by altering membrane lipid structures. This study therefore suggests an unexpected mechanism for how this crystalline structure interacts with the immune system and how the DC plasma membrane may behave as a general sensor for solid structures.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21399646     DOI: 10.1038/nm.2306

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  44 in total

1.  Syk regulation of phosphoinositide 3-kinase-dependent NK cell function.

Authors:  Kun Jiang; Bin Zhong; Danielle L Gilvary; Brian C Corliss; Eric Vivier; Elizabeth Hong-Geller; Sheng Wei; Julie Y Djeu
Journal:  J Immunol       Date:  2002-04-01       Impact factor: 5.422

2.  Analysis of the role of vaccine adjuvants in modulating dendritic cell activation and antigen presentation in vitro.

Authors:  Hongfan Sun; Kevin G J Pollock; James M Brewer
Journal:  Vaccine       Date:  2003-02-14       Impact factor: 3.641

3.  Exiting the outside world for cross-presentation.

Authors:  Kenneth L Rock
Journal:  Immunity       Date:  2006-10       Impact factor: 31.745

4.  The MAP kinase inhibitors, PD098059, UO126 and SB203580, inhibit IL-1beta-dependent PGE(2) release via mechanistically distinct processes.

Authors:  R Newton; L Cambridge; L A Hart; D A Stevens; M A Lindsay; P J Barnes
Journal:  Br J Pharmacol       Date:  2000-07       Impact factor: 8.739

5.  MyD88-dependent IL-1 receptor signaling is essential for gouty inflammation stimulated by monosodium urate crystals.

Authors:  Chun-Jen Chen; Yan Shi; Arron Hearn; Kate Fitzgerald; Douglas Golenbock; George Reed; Shizuo Akira; Kenneth L Rock
Journal:  J Clin Invest       Date:  2006-08       Impact factor: 14.808

Review 6.  Monosodium urate crystals in inflammation and immunity.

Authors:  Yan Shi; Ashley D Mucsi; Gilbert Ng
Journal:  Immunol Rev       Date:  2010-01       Impact factor: 12.988

7.  Investigation of a fatality from nonoccupational aluminum phosphide exposure: measurement of aluminum in tissue and body fluids as a marker of exposure.

Authors:  V F Garry; P F Good; J C Manivel; D P Perl
Journal:  J Lab Clin Med       Date:  1993-12

8.  A role of IgM antibodies in monosodium urate crystal formation and associated adjuvanticity.

Authors:  Uliana Kanevets; Karan Sharma; Karen Dresser; Yan Shi
Journal:  J Immunol       Date:  2009-02-15       Impact factor: 5.422

9.  Alum induces innate immune responses through macrophage and mast cell sensors, but these sensors are not required for alum to act as an adjuvant for specific immunity.

Authors:  Amy S McKee; Michael W Munks; Megan K L MacLeod; Courtney J Fleenor; Nico Van Rooijen; John W Kappler; Philippa Marrack
Journal:  J Immunol       Date:  2009-09-04       Impact factor: 5.422

10.  Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants.

Authors:  Stephanie C Eisenbarth; Oscar R Colegio; William O'Connor; Fayyaz S Sutterwala; Richard A Flavell
Journal:  Nature       Date:  2008-05-21       Impact factor: 49.962

View more
  142 in total

1.  Inflammasome components Asc and caspase-1 mediate biomaterial-induced inflammation and foreign body response.

Authors:  Ahsan F Malik; Rafaz Hoque; Xinshou Ouyang; Ayaz Ghani; Enping Hong; Khadija Khan; Laura Beth Moore; Gilbert Ng; Fay Munro; Richard A Flavell; Yan Shi; Themis R Kyriakides; Wajahat Z Mehal
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-22       Impact factor: 11.205

Review 2.  Inflammasomes in health and disease.

Authors:  Till Strowig; Jorge Henao-Mejia; Eran Elinav; Richard Flavell
Journal:  Nature       Date:  2012-01-18       Impact factor: 49.962

Review 3.  Single-cell force spectroscopy: mechanical insights into the functional impacts of interactions between antigen-presenting cells and T cells.

Authors:  Tong Seng Lim; Paola Ricciardi-Castagnoli
Journal:  Immunol Res       Date:  2012-09       Impact factor: 2.829

4.  To forge a solid immune recognition.

Authors:  Yan Shi
Journal:  Protein Cell       Date:  2012-08       Impact factor: 14.870

Review 5.  Technologies for enhanced efficacy of DNA vaccines.

Authors:  Fadi Saade; Nikolai Petrovsky
Journal:  Expert Rev Vaccines       Date:  2012-02       Impact factor: 5.217

Review 6.  Pediatric Vaccine Adjuvants: Components of the Modern Vaccinologist's Toolbox.

Authors:  David J Dowling; Ofer Levy
Journal:  Pediatr Infect Dis J       Date:  2015-12       Impact factor: 2.129

Review 7.  An update on the use of laser technology in skin vaccination.

Authors:  Xinyuan Chen; Ji Wang; Dilip Shah; Mei X Wu
Journal:  Expert Rev Vaccines       Date:  2013-10-16       Impact factor: 5.217

Review 8.  Key roles of adjuvants in modern vaccines.

Authors:  Steven G Reed; Mark T Orr; Christopher B Fox
Journal:  Nat Med       Date:  2013-12-05       Impact factor: 53.440

9.  Kinases conquer the inflammasomes.

Authors:  Konstantin Neumann; Jürgen Ruland
Journal:  Nat Immunol       Date:  2013-12       Impact factor: 25.606

10.  A biologic scaffold-associated type 2 immune microenvironment inhibits tumor formation and synergizes with checkpoint immunotherapy.

Authors:  Matthew T Wolf; Sudipto Ganguly; Tony L Wang; Christopher W Anderson; Kaitlyn Sadtler; Radhika Narain; Christopher Cherry; Alexis J Parrillo; Benjamin V Park; Guannan Wang; Fan Pan; Saraswati Sukumar; Drew M Pardoll; Jennifer H Elisseeff
Journal:  Sci Transl Med       Date:  2019-01-30       Impact factor: 17.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.